Research and development in the use of cord blood in the treatment of neurodegenerative illnesses is projected to provide attractive growth prospects for companies in the worldwide cord blood banking services market. For example, in April 2020, researchers from the University of L'Aquila in Italy claimed that cord blood serum-based eye drops might be used to successfully treat retinal neurodegenerative processes such as age-related macular degeneration.
Furthermore, the usage of cord blood in cancer detection and therapy is likely to contribute to Cord Blood Banking Services expansion. For example, researchers from Vinmec Healthcare System in Vietnam announced in March 2020 that frozen umbilical cord blood mononuclear cells source is successful in creating allogeneic dendritic cells and their exosomes may be employed for cancer vaccination.
Read the Blog- https://cmiblogdailydose.blogspot.com/2022/07/cord-blood-banking-services-has-become.html
